107 related articles for article (PubMed ID: 2276375)
21. Psychopharmacological profile of mesterolone.
Baran L; Przegaliński E
Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
[TBL] [Abstract][Full Text] [Related]
22. The influence of amphetamine and nomifensine on the development of morphine tolerance in the test of hypermotility in mice and catalepsy in rats.
Fidecka S; Langwiński R
Pol J Pharmacol Pharm; 1983; 35(6):503-10. PubMed ID: 6687158
[TBL] [Abstract][Full Text] [Related]
23. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
24. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
25. Central action of ketotifen.
Rogóz Z; Skuza G; Sowińska H
Pol J Pharmacol Pharm; 1981; 33(5):503-15. PubMed ID: 7335554
[TBL] [Abstract][Full Text] [Related]
26. [Effect of triquinol on the central nervous system].
Nikolov M; Stefanova D
Eksp Med Morfol; 1978; 17(4):194-201. PubMed ID: 729527
[TBL] [Abstract][Full Text] [Related]
27. Some central effects of indenolol in experimental animals.
Tariq M; Babhair SA; Ageel AM; Ginawi OT; Parmar NS
Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):201-9. PubMed ID: 2878478
[TBL] [Abstract][Full Text] [Related]
28. Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Pol J Pharmacol; 1995; 47(6):501-7. PubMed ID: 8868372
[TBL] [Abstract][Full Text] [Related]
29. Reserpine-induced central effects: pharmacological evidence for the lack of central effects of reserpine methiodide.
Nammi S; Boini KM; Koppula S; Sreemantula S
Can J Physiol Pharmacol; 2005 Jun; 83(6):509-15. PubMed ID: 16049551
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological properties of a new fluoroquinolone on the central nervous system in rodents.
Guiol C; Ledoussal C; Surgé JM
Arzneimittelforschung; 1993 Jan; 43(1):56-60. PubMed ID: 8447850
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties.
Yamasaki T; Kojima H; Tanaka M; Aibara S; Hirohashi M; Kasai Y; Tsubokawa M; Watanabe K; Akashi A
Arzneimittelforschung; 1981; 31(4):707-15. PubMed ID: 6113834
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological effects of deltamethrin on the central nervous system.
Pham Huu Chanh ; Navarro-Delmasure C; Pham Huu Chanh ; Cheav SL; Ziade F; Samaha F
Arzneimittelforschung; 1984; 34(2):175-81. PubMed ID: 6539110
[TBL] [Abstract][Full Text] [Related]
33. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
[TBL] [Abstract][Full Text] [Related]
34. General pharmacology of beraprost sodium. 1st communication: effect on the central nervous system.
Murata T; Sakaya S; Hoshino T; Umetsu T; Hirano T; Nishio S
Arzneimittelforschung; 1989 Aug; 39(8):860-6. PubMed ID: 2510742
[TBL] [Abstract][Full Text] [Related]
35. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
[TBL] [Abstract][Full Text] [Related]
36. [Studies on the CNS activity profile of thalidomide analogs (author's transl)].
Friderichs E
Arzneimittelforschung; 1982; 32(6):613-20. PubMed ID: 7202366
[TBL] [Abstract][Full Text] [Related]
37. Central action of 2-amino- and 2-amino-5-aryltetrahydropyrimidinediones-4,6.
Wilimowski M; Witkowska M; Barczyńska J; Kedzierska L; Orzechowska-Juzwenko K; Wojewódzki W; Felsztyńska J
Arch Immunol Ther Exp (Warsz); 1975; 23(4):569-79. PubMed ID: 1164157
[TBL] [Abstract][Full Text] [Related]
38. [Effect of aligeron and cinnarizine on the behavior of experimental animals].
Nikolova M; Stefanova D; Nikolov R
Eksp Med Morfol; 1980; 19(4):212-6. PubMed ID: 7460809
[TBL] [Abstract][Full Text] [Related]
39. Central effects of endothelin-1 (ET-1) and endothelin-3 (ET-3) in mice.
Maslarova J; Getova D; Semkova I; Nikolov R
Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):431-6. PubMed ID: 8577203
[TBL] [Abstract][Full Text] [Related]
40. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
